Founding CEOS of SureScripts(R) and RxHub(R) Join Forces to Deliver Clinical Information Technology Services to Physician Practices

Wednesday, February 13, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

BETHESDA, Md., Feb. 12 Prematics today announced that ithas named Kevin Hutchinson, one of the nation's most respected experts inhealth information technologies and the former president and chief executiveofficer of SureScripts, to lead the company's next phase of growth aspresident and CEO.

(Logo: )

"Kevin is an industry renowned champion of health information technology,having spearheaded the development and successful growth of SureScripts,operators of the nationwide Pharmacy Health Information Exchange," saidPrematics Chairman James Bradley. "In particular, his proven ability tosuccessfully build interoperable healthcare solutions makes him an invaluableasset for the next stage of Prematics' growth. I'm excited to work side-by-side with Kevin as we take on this new challenge to further the adoption andutilization of electronic prescribing for physician practices."

Prematics offers physician practices clinical information technologyservices in an elegant easy-to-use interface that improve efficiency andenable more informed decision making at the point of care. The companyemploys a unique, service-based strategy that overcomes common barriers tophysician adoption. It provides ongoing physician support and fully managesall aspects of its services, including equipment and connectivity, at nocharge to the physician practice.

During the past year, Prematics used this approach to successfully deployScriptTone(SM), the company's electronic prescribing service, in CentralPennsylvania. A first-of-its-kind initiative, the effort was designed to drivewidespread adoption among physicians in a specified geographic region. Withsuccess achieved from its initial deployment, Prematics has enhanced itsservice implementation process and application, and is now evaluating severalnew markets for its next deployment.

"Now that the critical infrastructure is in place, Prematics is in a greatposition to take advantage of the strong momentum to transform the way inwhich prescriptions are written today. Its unique approach to driving theutilization of electronic prescribing means Prematics partners with physicianpractices and is invested in their success. This is what physicians arelooking for when they consider automating the exchange of clinical informationand transactions like electronic prescribing," said Hutchinson. "I lookforward to working with the strong team of industry leaders Prematics hasassembled to move the company into its next phase of development and choosingthe next market for electronic prescribing deployment."

Mr. Hutchinson, regarded nationally as a leading expert on healthcaretechnology, has given testimony before the various Senate and House Committeesas well as the National Committee on Vital and Health Statistics, helping toclear the path to providing meaningful incentives to physicians and pharmaciesfor adopting electronic prescribing. His mission remains clear -- thatelectronic prescribing must remain a national priority.

As president and CEO of Prematics, Mr. Hutchinson will serve on thecompany's board of directors, which is chaired by James Bradley, the foundingCEO of RxHub and one of the nation's most experienced healthcare executives.Prematics is backed by two top-tier private equity firms, General CatalystPartners and Foundation Capital. Ken Novack, special advisor to GeneralCatalyst Partners and former vice chairman of both America Online (AOL) andTime Warner, also serves on Prematics' board of directors, as does RichRedelfs, general partner of Foundation Capital, who has more than 20 years ofexperience in networking and communications.

Mr. Hutchinson currently serves as a member of the American HealthInformation Community (AHIC) in addition to a number of leading industryorganizations. He was appointed by Secretary Leavitt to ser

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store